Disparate areas of machine learning have benefited from models that can take raw data with little preprocessing as input and learn rich representations of that raw data in order to perform well on a given prediction task. We evaluate this approach in healthcare by using longitudinal measurements of lab tests, one of the more raw signals of a patient's health state widely available in clinical data, to predict disease onsets. In particular, we train a Long Short-Term Memory (LSTM) recurrent neural network and two novel convolutional neural networks for multi-task prediction of disease onset for 133 conditions based on 18 common lab tests measured over time in a cohort of 298K patients derived from 8 years of administrative claims data. We compare the neural networks to a logistic regression with several hand-engineered, clinically relevant features. We find that the representationbased learning approaches significantly outperform this baseline. We believe that our work suggests a new avenue for patient risk stratification based solely on lab results.
Introduction
The recent success of deep learning in disparate areas of machine learning has driven a shift towards machine learning models that can learn rich, hierarchical representations of raw data with little preprocessing and away from models that require manual construction of features by experts (Graves and Schmidhuber, 2005; Krizhevsky et al., 2012; Mikolov et al., 2013) . In natural language processing, for example, neural networks taking only character-level input achieve high performance on many tasks including text classification tasks (Zhang et al., 2015; Kim, 2014) , machine translation (Ling et al., 2015) and language modeling (Kim et al., 2016) .
Following these advances, attempts to learn features from raw medical signals have started to gain attention too. Lasko et al. (2013) studied a method based on sparse autoencoders to learn temporal variation features from 30-day uric acid observations to distinguish between gout and leukemia. Che et al. (2015) developed a training method which, when datasets are small, allows prior domain knowledge to regularize the deeper layers of a feed-forward network for the task of multiple disease classification. Recent studies (Lipton et al., 2015; Choi et al., 2015) used Long Short-Term Memory (LSTM) recurrent neural networks (RNNs) for disease phenotyping.
In this paper, we evaluate the representation-based learning approach in healthcare by using longitudinal measurements of laboratory tests, one of the more raw signals of a patient's health state widely available in clinical data, to predict disease onsets. We show that several multi-task neural networks, including a LSTM RNN and two novel convolutional neural networks, can aid in early diagnosis of a wide range of conditions (including conditions that the patient was not specifically tested for) without having to hand-engineer features for each condition. The source code of our implementation is available at https://github. com/clinicalml/deepDiagnosis. Figure 1 outlines the study's prediction framework. Our goal is early diagnosis of diseases for people who do not already have the disease. We required a 3-month gap between the end of the backward window, denoted t, and the start of the diagnosis window. The purpose of the 3 month gap was to ensure that the clinical tests taken right before the diagnosis of a disease would not allow our system to cheat in the prediction of that disease. Each output label was defined as positive if the diagnosis code for the disease was observed in at least 2 distinct months between 3 to 3 + 12 months after t. Using 12 months helps alleviate the noisy label problem. Requiring at least 2 observations of the code also reduced the noise coming from physicians who report their wrong suspected diagnosis as a diagnosis. For each disease, we excluded individuals who already have the disease by time t + 3. For exclusion, we required only 1 diagnosis record instead of 2 in order to remove patients who are even suspected of having the disease previously. This results in a more difficult, but more clinically meaningful prediction task.
Prediction Task
Formally, we define the task of diagnosis as a supervised multi-task sequence classification problem. Each individual has a variable-length history of lab observations (X) and diagnosis records (Y ). X is continuous valued and Y is binary. We use a sliding window framework to deal with variable length input. At each time point t for each person, the model looks at a backward window of B months of all D biomarkers of the input, X 1:D t−B:t , to predict the output. The output is a binary vector Y of length M indicating for each of the M diseases whether they are newly diagnosed in the following months t + 3 to t + 3 + 12, where 3 is the gap and 12 is the prediction window.
Cohort
Our dataset consisted of lab measurement and diagnosis information for 298,000 individuals. The lab measurements had the resolution of 1 month and we used a backward window of 36 months for each prediction. These individuals were selected from a larger cohort of 4.1 million insurance subscribers between 2005 and 2013. We only included members who had at least one lab measurement per year for at least 3 consecutive years.
We used lab tests that comprise a comprehensive metabolic panel plus cholesterol and bilirubin (18 lab tests in total), which are currently recommended annually and covered by most insurance companies in the United States. The names and codes of the labs used in our analysis are included in the Supplementary Materials. Each lab value was normalized by subtracting its mean and dividing by the standard deviation computed across the entire dataset. We randomly divided individuals into a 100K training set, a 100K validation set, and a 98K test set. The validation set was used to select the best epoch/parameters for models and prediction results are presented on the test set unseen during training and validation.
The predicted labels corresponded to diagnosis information for these individuals. In our dataset, each disease diagnosis is recorded as an ICD9-CM (International Classification of Diseases, Ninth Revision, Clinical Modification) code.
Methods
We now describe the baseline model, the two novel convolutional (Le Cun et al., 1990; LeCun et al., 1998) architectures and the recurrent neural network with long short-term memory units (Hochreiter and Schmidhuber, 1997) that we evaluate on this prediction task. The input to the baseline model are hand-engineered features derived from the patient's lab measurements, whereas the input to the representation-based models are the raw, sparse and asynchronously measured lab measurements. We also report the results of an ensemble of the representation-based models.
Baseline
We trained a Logistic Regression model on a large set of features derived from the patient's lab measurements. These features included the minimum, maximum and latest observation value for each of the labs as well as binary indicators for increasing and decreasing trends in the lab values within the backward window. The continuous features were computed on lab values that were normalized across the cohort (to have zero mean and unit variance). We used the validate data to choose the type and amount of L1, L2, and Dropout (Srivastava et al., 2014) regularization, separately for each disease.
Multi-resolution Convolutional Neural Network (CNN1)
The architecture for our first convolutional neural network is shown in Figure 2 . We define X 1:D t−B:t to be the input to the network at time t for D lab measurements over the past B months. Let J be the number of filters in each convolution operator. Each filter 
which is defined as follows:
In the equations above, the nonlinearity f is a rectified linear unit (ReLU) (Nair and Hinton, 2010) applied element-wise to a vector, and * is the standard convolution operation. MaxPool(Z, s) corresponds to a non-overlapping max pooling operation with step size k, defined as MaxPool(Z, s)[i] = max(Z i·s , . . . , Z (i+1)·s−1 ) for i = 1 : length(Z)/s . We set p = 3 for this paper. The vector C i is the concatenation of C After the multi-resolution convolution is applied, the vector C = [C 1 , C 2 , C 5 ] represents the application of filters to all labs (note that the filters are shared across all the labs). We then use 2 layers of hidden nodes to allow non-linear combination of filter activations on different labs: W i are the weights for the hidden nodes and b h i is the bias associated with each layer. Each of the hidden layers are subject to Dropout regularization (with probability 0.5) during training, and are followed by batch normalization.
Finally, for each disease m = 1 : M , the model predicts the likelihood of the disease via logistic regression over h 2 :
where σ(x) = 1/(1 + e −x ) is the sigmoid function. The loss function for each disease is the negative log likelihood of the true label, weighted by the inverse-label frequency to handle class imbalance during multi-task batch training. Diseases are trained independently, but the gradient is backpropagated through the shared part of the network for all diseases.
Convolutional Neural Network over Time and Input dimensions (CNN2)
The architecture for our second convolutional neural network is shown in Figure 3 . In this model, we first combine the labs via a vertical convolution with kernels that span across all labs. Having a few such combination layers enables us to project from the lab space into a new latent space which might better encode information about the labs. We then focus on temporal encoding of the result in the new space. Given the input X 1:D t−B:t , the output of the first vertical convolution with L filters K 1:L , each of size (D × 1), and nonlinearity f is V
for l = 1 : L. We then repeat, applying new convolution filters of size L × 1 to V t−B:t 1:L , followed again by a nonlinearity f (ReLU in our experiments), giving us two hidden layers in the vertical direction. Finally, temporal max pooling and convolution is applied to the last convolution output followed by two fully connected layers, similar to equations (2) and (6) through (8). Similar to the previous architecture, we optimize the weighted negative log-likelihood of the disease labels on the training data. 
Long Short-Term Memory Network (LSTM)
The architecture for the Recurrent Neural Network with Long Short-Term Memory units (Hochreiter and Schmidhuber, 1997) is shown in Figure 4 . These models encode a memory state ct at each time stept, which is only accessible through a particular gating mechanism. Given input Xt and the output and memory state of the recurrent network at timet − 1 (ht −1 ), the memory state and output for time stepst : t − B : t are computed as follows:
where W * and b * are the network's parameters, shared across all time steps. We use the output of the last time point, h t , as the patient representation (i.e. C in Eq. (6)). The rest of the network is the same as described in Eq. (6) through (8) and we minimize the weighted negative log-likelihood.
Weighted Batch Training to Deal with Class Imbalance
We observed in our initial experiments that the predictive performance for more common diseases converges faster than for the uncommon diseases. Since early stopping is so important for preventing overfitting in neural networks, this leads to the following dilemma: either we stop early and underfit for the less common diseases, or we continue learning and overfit for the more common diseases. Decoupling them is not possible because of the shared patient representation. To alleviate this problem and following Firat et al. (2016), we use a weighted negative log-likelihood as the loss function. Specifically, we weight the gradient coming from each disease by the frequency of that disease. Our experiments indicated that the weighting improves the overall prediction results.
Results
We used the validation set of 100K individuals to fine tune the hyperparameters of all our models. We then evaluated the best models on a test set of size 98K individuals. We describe the details of the architectures chosen in the Supplementary Materials. We report the Area Under the ROC curve (AUC) on the test set. We implemented these experiments in Torch (Collobert et al., 2011) . The source code of our implementation is available at https://github.com/clinicalml/deepDiagnosis. Table 1 shows the AUC results for the top 25 diseases sorted by the maximum AUC that any model achieved on the test set. An ensemble of the neural networks performed best followed by the CNN2 architecture. The neural networks consistently outperformed the baseline in predicting the new onset of diseases 3 months in advance. In particular, heart failure, severe kidney diseases and liver problems, diabetes and hormone related conditions, and prostate cancer are among the diseases most accurately detected early from only 18 common lab measurements tracked over the previous 3 years. Our proposed models improve the quality of prediction for prostate cancer, elevated prostate specific antigen (note that the PSA lab is not part of our input), breast cancer, colon cancer, macular degeneration, and congestive heart failure most strongly. In the Supplementary Materials, we also report the top features from the baseline model for several of the diseases.
Case study: Chronic Kidney Disease Progression
We adapted the multitask architecture to predict the onset of end-stage renal disease (ESRD) requiring dialysis or a kidney transplant based on labs related to kidney function as well as diagnoses and prescriptions in a cohort of patients with advanced chronic kidney disease (CKD).
Predictive models for ESRD in patients with advanced kidney disease could improve the timeliness of referral to a nephrologist enabling, for example, early counseling and education for high risk patients before they start dialysis (Green et al., 2012) . Clinical guidelines recommend that patients be referred to a nephrologist at least one year before they might be anticipated to require dialysis, and late referral may result in more rapid progression to kidney failure, worse quality of life for patients on dialysis, and missed opportunities for pre-emptive kidney transplantation (UK-Renal-Assocation, 2014) .
See Echouffo-Tcheugui and Kengne (2012) 
Data and Experiments Setup
We use the same dataset as in the multi-disease prediction task. We restrict our analysis to patients with Stage 4 CKD, which we define as patients with at least 2 measurements of the estimated Glomerular Filtration Rate (eGFR) between 15 and 30 mL/min/1.73m 2 observed at least 90 days apart (KDIGO, 2012 requiring at least one measurement of eGFR every 4 months of the training window. NICE (2014) recommends 2-3 measurements of eGFR a year for patients with Stage 4 CKD. We formulate the prediction task as taking a year of a patient's lab, diagnosis, prescription and demographic data as input and outputting a guess for whether or not that patient will start dialysis or undergo a kidney transplantation at any point in a 1-year window starting 3 months after the end of that year of clinical data. A training example for this prediction task consists of a matrix X for a patient-year with X[i, j] = the value of the ith clinical or demographic feature (the average value for each lab, an indicator for each ICD9 code and drug class prescription, an indicator for gender and a continuous value for age) for the patient in the jth month of the year and an indicator Y with Y = 1 if the patient starts dialysis or undergoes a kidney transplantation in the 1-year outcome window and 0 otherwise.
We included the labs associated with the most common LOINC codes for all of the labs used in the predictive models for kidney failure developed by Tangri et al. (2011) and the labs with high prevalence in the CKD cohort analyzed by Hagar et al. (2014) . We also included drug classes common in the treatment of kidney disease (HealthPartners-KidneyHealth-Clinic, 2011) and ICD9 codes with high mutual information comparing positive to negative examples on the training data (withholding the validation and test data). Table 3 shows the final list of clinical features.
For each patient in the cohort, we obtain multiple training examples by constructing an X for the one-year period starting at the 1st observation of eGFR for that patient, another X for the one-year period starting at the 2nd observation of eGFR for that patient, and so on for every observation of eGFR in the patient's record. We exclude training examples where a dialysis CPT code appears before the start of the 1-year outcome window.
This process results in 29,937 examples (5,484 patients) with 2,619 positive examples (781 patients). We randomly divide these patients into 3 roughly equal groups and assign all the examples for a patient to the training, validation or test dataset. Figure 5 in the Supplementary Materials shows an example of lab data for a patient that does not start dialysis or undergo a kidney transplant in the outcome window and for a patient the starts dialysis in the outcome window.
We compared the performance of the CNN2 architecture adapted to this prediction task to two logistic regression baselines and a random forest. Additional details are provided in the Supplementary Materials.
Results
The 4 models achieved similar performance on this prediction task (see Table 4 ). The small sample size and the single binary outcome distinguish this task from the multi-disease setting and may make it difficult to observe large differences in performance between the models. A small number of features also seem to account for much of the signal. We observed that a logistic regression with a large L1 penalty achieves good performance on the task despite only using eGFR, urea nitrogen, age and gender as features.
Conclusion
In this work, we presented a large-scale application of two novel convolutional neural network architectures and a LSTM recurrent neural network for the task of multi-task early disease onset detection. These representation-based approaches significantly outperform a logistic regression with several hand-engineered, clinically relevant features. Interestingly, in our earlier work, we found that despite the large amount of missing data in the setting considered, preprocessing the data by imputing missing values did not significantly improve results (Razavian and Sontag, 2015) . As medical home and consumer healthcare technologies rapidly progress, we envision a growing role for automatic risk stratification of patients based solely on raw physiological and chemical signals. 
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Cross-validation results
For the convolutional models, we set the number of filters to be 64 for all the convolution layers with a kernel length of 8 (months) and a step size of 1. Each max-pooling module had a horizontal length of 3 and vertical length of 1 with a step size of 3 in the horizontal direction (i.e. no overlap). Each convolution module was followed by a batch normalization module (Ioffe and Szegedy (2015)) and then a ReLU nonlinearity (Nair and Hinton (2010)). We had 2 fully connected layers (with 100 nodes each, cross validated over [30, 50, 100, 500 ,1000]) after concatenating the outputs of all the convolution layers. Each of the fully connected layers were followed by a batch normalization layer and a ReLU nonlinearity layer. We also added one Dropout module (Srivastava et al. (2014)) (0.5 dropout probability) before each fully connected layer. We tested models with and without batch-normalization and found that the networks converge much faster with batch-normalization. We had the following layers after the last ReLu nonlinearity for each of the 171 diseases: a Dropout layer(0.5 dropout probability), a fully connected layer (of size 2 nodes corresponding to binary outcome), a batch normalization layer and a Log Softmax Layer. A learning rate of 0.1 was selected from among the values [0.001, 0.01, 0.05, 0.1, 1] using the validation set average AUC (over all diseases) after 10 epochs. Training was done using Adadelta(Zeiler (2012)) optimization, which is a variant of stochastic gradient descent with adaptive step size. We used mini-batches of size 256.
For the LSTM network, we cross-validated over the hidden LSTM units ([100 500 1000]), and 500 was selected as the best. For the shared part of the network, we used the best parameters found for the convolution models.
Model details for CKD Case Study
We compared the following models:
• CNN2. We applied the CNN2 architecture used in the multi-disease prediction task with 8 filters with kernel dimensions of 8x1. We used the raw clinical and demographic data as input without additional feature engineering. We chose the learning rate and the architecture based on cross-validation using random sampling of hyperparameters (Bergstra and Bengio (2012)).
• L2-regularized, logistic regression. For each lab, we added one feature for the average lab value across the training window. We included gender and the diagnosis and prescription data as binary indicators and age as a continuous variable. We chose a regularization constant based on cross-validation.
• L1-regularized, logistic regression. For each lab, we added features to the regression for the average lab value for the patient over the last 3 months of the training window, the past 6 months of the training window and over the entire training window. We also added binary features for whether or not the lab increased, decreased or fluctuated over the last 3 months, 6 months and over the entire training window. We included gender and the diagnosis and prescription data as binary indicators and age as a continuous variable. We chose a regularization constant based on cross-validation.
• Random forests. We used the raw clinical and demographic data as input without additional feature engineering. We chose the number of trees in the forest, the maximum depth of each tree, the maximum number of features to consider when looking for the best split, the minimum number of samples required to split a node, and the minimum number of samples in newly created leaves based on cross-validation using random sampling of hyperparameters. 
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